Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Zinc finger protein 57 (ZNF57, also called ZFP57 or Zinc finger protein 424) is a nuclear transcription factor containing KRAB zinc finger domains, which enable DNA binding and regulation of gene expression through modulation of DNA methylation. ZNF57 plays a significant role in the maintenance of DNA methylation at imprinted genomic regions, enabling heritable gene silencing or activation as needed for normal development and metabolism. Mutations in ZNF57 are linked to conditions such as transient neonatal diabetes mellitus and can disrupt normal imprinting, leading to a generalized impairment of gene silencing across multiple loci[1][2][4]. There is no current evidence establishing ZNF57 as a direct drug target or with approved therapeutic modulators.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Zinc finger protein 57 (ZNF57).